Redox regulation of Ito remodeling in diabetic rat heart

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 3 57-3, 2005, Pages

  Li, Xun ^a,b   Xu, Zhi ^a   Li, Shumin ^a   Rozanski, George J ^a,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b SOOCHOW UNIVERSITY   (China)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Glutaredoxin; Insulin; Potassium; Thioredoxin; Transient outward current

Indexed keywords

DICHLOROACETIC ACID; ENZYME INHIBITOR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTAREDOXIN; GLUTATHIONE REDUCTASE; INSULIN; ION CHANNEL; OXIDOREDUCTASE; POTASSIUM CHANNEL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REGULATOR PROTEIN; THIOREDOXIN; THIOREDOXIN REDUCTASE; GLUTATHIONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; HEART VENTRICLE REMODELING; HYPERGLYCEMIA; IN VITRO STUDY; ISOLATED HEART; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SPECTROPHOTOMETRY; STREPTOZOCIN DIABETES; VOLTAGE CLAMP; ANIMAL; CARDIOMYOPATHY; CELL MEMBRANE POTENTIAL; DRUG EFFECT; HEART MUSCLE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CARDIOMYOPATHIES; DIABETES COMPLICATIONS; DICHLOROACETATE; GLUTATHIONE; INSULIN; MALE; MEMBRANE POTENTIALS; MYOCARDIUM; OXIDATION-REDUCTION; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; THIOREDOXIN; VENTRICULAR REMODELING;

EID: 13944255443     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00559.2004     Document Type: Article

References (36)

1. Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D, Cooksey RC, McClain DA, Litwin SE, Taegtmeyer H, Severson D, Kahn CR, and Abel ED. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 109: 629-639, 2002.
2. Bidasee KR, Nallani K, Besch HR, and Dincer UD. Streptozotocin-induced diabetes increases disulfide bond formation on cardiac ryanodine receptor (RyR2). J Pharmacol Exp Ther 305: 989-998, 2003.
3. Carlberg I and Mannervik B. Glutathione reductase. Methods Enzymol 113: 484-490, 1985.
4. Casagrande S, Bonetto V, Fratelli M, Gianazza E, Eberini I, Massignan T, Salmona M, Chang G, Holmgren A, and Ghezzi P. Glutathionylation of human thioredoxin: a possible crosstalk between glutathione and thioredoxin systems. Proc Natl Acad Sci USA 99: 9745-9749, 2002.
5. Casis O, Gallego M, Iriarte M, and Sanchez-Chapula JA. Effects of diabetic cardiomyopathy on regional electrophysiologic characteristics of rat ventricle. Diabetologia 43: 101-109, 2000.
6. De Cavanagh EMV, Inserra F, Toblli J, Stella I, Fraga CG, and Ferder L. Enalapril attenuates oxidative stress in diabetic rats. Hypertension 38: 1130-1136, 2001.
7. Dhehadeh A and Regan TJ. Cardiac consequences of diabetes mellitus. Clin Cardiol 18: 301-305, 1995.
8. Eckel J and Reinauer H. Insulin action on glucose transport in isolated cardiac myocytes: signaling pathways and diabetes induced alterations. Biochem Soc Trans 18: 1125-1127, 1990.
9. Fazekas T, Lengyei C, Varkonyi T, Legradi P, and Boda K. QT dispersion in diabetes mellitus (Abstract). J Mol Cell Cardiol 27: A422, 1995.
10. Fernandes AP and Holmgren A. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal 6: 63-74, 2004.
11. Holmgren A and Björnstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol 252: 199-208, 1995.
12. Jain M, Brenner DA, Cui L, Lim CC, Wang B, Pimental DR, Koh S, Sawyer DB, Leopold JA, Handy DE, Loscalzo J, Apstein CS, and Liao R. Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adults cardiomyocytes. Circ Res 93: e9-e16, 2003.
13. Jain M, Cui L, Brenner DA, Wang B, Handy DE, Leopold JA, Loscalzo J, Apstein CS, and Liao R. Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase. Circulation 109: 898-903, 2004.
14. Jung CH and Thomas JA. S-glutathiolated hepatocyte proteins and insulin disulfides as substrates for reduction by glutaredoxin, thioredoxin, protein disulfide isomerase, and glutathione. Arch Biochem Biophys 335: 61-72, 1996.
15. Jurado J, Prieto-Alamo MJ, Madrid-Risquez J, and Pueyo C. Absolute gene expression patterns of thioredoxin and glutaredoxin redox systems in mouse. J Biol Chem 278: 45546-45554, 2003.
16. Magyar J, Rusznak Z, Szentesi P, Szucs G, and Kovacs L. Action potential and potassium currents in rat ventricular muscle during experimental diabetes. J Mol Cell Cardiol 24: 841-853, 1992.
17. Maritim AC, Sanders RA, and Watkins JB. Diabetes oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17: 24-38, 2003.
18. Miyamoto M, Kishimoto C, Shioji K, Nakamura H, Toyokumi S, Nakayama Y, Kita M, Yodoi J, and Sasayama S. Difference in thioredoxin expression in viral myocarditis in inbred strains of mice. Jpn Circ J 65: 561-564, 2001.
19. Näbauer M and Kääb S. Potassium channel down-regulation in heart failure. Cardiovasc Res 37: 324-334, 1998.
20. Nakamura H, Nakamura K, and Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 15: 351-369, 1997.
21. Okuda M, Inoue N, Azumi H, Seno T, Sumi Y, Hirata K, Kawashima S, Hayashi Y, Itoh H, Yodoi J, and Yokoyama M. Expression of glutaredoxin in human coronary arteries. Its potential role in antioxidant protection against atherosclerosis. Arterioscler Thromb Vasc Biol 21: 1483-1487, 2001.
22. to) in normal and diseased myocardium. J Mol Cell Cardiol 33: 851-872, 2001.
23. Paget MSB and Buttner MJ. Thiol-based regulatory switches. Annu Rev Genet 37: 91-121, 2003.
24. Powis G, Mustacichi D, and Coon A. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic Biol Med 29: 312-322, 2000.
25. + channel genes expression in type I diabetic cardiomyopathy. Biochem Biophys Res Commun 283: 549-553, 2001.
26. Raghavachari N and Lou MF. Evidence for the presence of thioltransferase in the lens. Exp Eye Res 63: 433-441, 1996.
27. Rodrigues B, Cam MC, and McNeill JH. Myocardial substrate metabolism: implications for diabetic cardiomyopathy. J Mol Cell Cardiol 27: 169-179, 1995.
28. + channel remodeling. Clin Exp Pharmacol Physiol 29: 132-137, 2002.
29. Schallreuter KU, Gleason FK, and Wood JM. The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase. Biochim Biophys Acta 1054: 14-20, 1990.
30. + currents depends on the integrity of the cytoskeleton. J Physiol 514: 735-745, 1999.
31. Shimoni Y, Chuang M, Abel ED, and Severson DL. Gender-dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice. J Physiol 555: 345-354, 2003.
32. Shioji K, Kishimoto C, Nakamura H, Toyokuni S, Nakayama Y, Yodoi J, and Sasayama S. Upregulation of thioredoxin (TRX) expression in giant cell myocarditis in rats. FEBS Lett 472: 109-113, 2000.
33. + current in ventricular myocytes from diabetic rats. Am J Physiol Heart Circ Physiol 271: H2154-H2161, 1996.
34. + current in ventricular myocytes from diabetic rats. Am J Physiol Heart Circ Physiol 271: H2190-H2196, 1996.
35. + channels in diabetic rat ventricular myocytes by insulin and glutathione. Cardiovasc Res 53: 80-88, 2002.
36. Yamawaki H, Haendeler J, and Berk BC. Thioredoxin: a key regulator of cardiovascular homeostasis. Circ Res 93: 1029-1033, 2003.